LRMR
Larimar Therapeutics Inc.
$4.20
-$0.16(-3.67%)
55
Overall
60
Value
66
Tech
39
Quality
Market Cap
$359.48M
Volume
1.65M
52W Range
$1.61 - $9.50
Target Price
$16.70
Key Metrics Overview
| Market Cap | $359.48M | P/E Ratio | N/A |
| 52W High | $9.50 | 52W Low | $1.61 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 23.5% | 52W Position | 32.8% |
| Overall Score | 55 | Value Score | 60 |
| Quality Score | 39 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-1.63 | EPS Next Est | $-1.49 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $4.20 | -3.7% | 1.65M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW